Agrinos Receives OMRI Certification for iNvigorate, B Sure and Agrinos 5-0-0
OSLO, Norway and DAVIS, Calif (April 4, 2016)―Agrinos, a leading biological crop input provider committed to improving the productivity and sustainability of agriculture, is pleased to announce iNvigorate®, B Sure® and Agrinos 5-0-0 have received Organic Materials Review Institute (OMRI) certification. OMRI is widely recognized as the leading independent source of verification that products meet U.S. National Organic Standards requirements.
Agrinos Announces Rudolf von Plettenberg as New Member to its Board of Directors
OSLO, Norway (February 8, 2016) ― Agrinos AS (“Agrinos”), a global leader in biological crop nutrition products, is pleased to announce the addition of Rudolf Graf von Plettenberg its Board of Directors. Mr. Plettenberg was approved to serve on the Board of Agrinos by shareholders at an Extraordinary General Assembly meeting held in Oslo, Norway on February 5, 2016.
Agrinos and EuroChem Sign Equity Investment and Two Collaboration Agreements
Oslo, Norway and Zug, Switzerland, January 28, 2016 ― EuroChem Group AG (“EuroChem”), a leading global agrochemical company, and Agrinos AS (“Agrinos”), a global leader in biological crop nutrition products, have today jointly signed an equity investment and two strategic collaboration agreements.
Notice of an Extraordinary General Meeting in Agrinos AS
Oslo, Norway (January 28, 2016) ― The Board of Directors of Agrinos AS gives notice of an extraordinary general meeting (EGM) of the company to be held on 5 February 2016 at 13:00 hours at Advokatfirma DLA Piper, Bryggegata 6, 0250 Oslo, Norway.
Agrinos AS Conducts Private Placement with Manor Investment SA, Havfonn AS, and EuroChem Group AG to Support Long-term Growth Strategy
Oslo, Norway (January 28, 2016) ― Agrinos AS (“Agrinos” or the “Company”), a global leader in biological crop nutrition products, today announces that the Company, subject to the approval by an extraordinary general meeting to be held on or about 5 February 2016, has completed a private placement of new shares with the support of long-term strategic investors Manor Investment SA ("Manor") and Havfonn AS and affiliated companies ("Havfonn"), as well as a new share issue directed towards EuroChem Group AG ("EuroChem") to support the Company’s long-term growth strategy.